Research area · week to 3 Oct 2026

Gastroesophageal reflux and treatments

Moving in Gut.

Moved this week: 1

Rebuilt 3 October 2026 at 4:06 pm AEST

Moved this week

Everything that moved →

Rome V global epidemiology and validation survey: prevalence of disorders of gut-brain interaction and comparison with the Rome IV global epidemiology study.
Gut · 7 Sept 2026 · Comparative Study
The global prevalence of disorders of gut-brain interaction remains consistent at around 41% using Rome V criteria, confirming high worldwide burden.
- Open access
- 2 cites
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42613194
Open in JClub

Latest in Gastroesophageal reflux and treatments

Newest first · last 60 days

Rome V global epidemiology and validation survey: prevalence of disorders of gut-brain interaction and comparison with the Rome IV global epidemiology study.
Gut · 7 Sept 2026 · Comparative Study
The global prevalence of disorders of gut-brain interaction remains consistent at around 41% using Rome V criteria, confirming high worldwide burden.
- Open access
- 2 cites
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42613194
Open in JClub
Multinational prevalence and burden of paediatric disorders of gut-brain interaction: results of the Rome Foundation paediatric global study.
Gut · 7 Sept 2026 · Journal Article
Read the brief in JClub
- Open access
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42613193
Open in JClub
New frontier in albumin replacement therapy.
Gut · 7 Sept 2026 · Journal Article
Read the brief in JClub
- 1 cites
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/40695621
Open in JClub
The Management of Chest Pain: Differentiating Cardiac and Esophageal Causes.
Gastroenterology · 2 Sept 2026 · Journal Article
Read the brief in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42686046
Open in JClub
Risk of Stomach Cancer With Long-Term Use of Proton Pump Inhibitors.
Gastroenterology · 1 Sept 2026 · Journal Article
Read the brief in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/41759635
Open in JClub
Achalasia and Risk of Esophageal Squamous Cell Carcinoma and Adenocarcinoma in a Multinational Study.
Gastroenterology · 1 Sept 2026 · Multicenter Study
Achalasia is strongly linked to esophageal squamous cell carcinoma, with an odds ratio of 9.46, but its connection to adenocarcinoma is weaker and largely explained by GERD.
- Open access
- 1 cites
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42019768
Open in JClub
Surgical and Endoscopic Therapies for GERD.
JAMA · 1 Sept 2026 · Journal Article
Surgical and endoscopic therapies, including radiofrequency, plication, and mucosal resection, offer diverse options for treating GERD patients.
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42384419
Open in JClub
Evaluating NGS variant callers in a challenging genomic context with a focus on the PRSS1-PRSS2 locus for hereditary pancreatitis.
Gut · 6 Aug 2026 · Letter
Read the brief in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/41249032
Open in JClub
Letter in reply: should SNRIs be considered the most effective neuromodulators for IBS?
Gut · 5 Aug 2026 · Letter
Read the brief in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42557052
Open in JClub

Follow this area in the app

Journals this month

All journals →

Moving areas, week to 3 Oct 2026

All research areas →

Read

Moved this week

Latest in Gastroesophageal reflux and treatments

Browse JClub